Dalian BIO-CHEM Co Ltd
SSE:603360
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (25.4), the stock would be worth ¥9.96 (58% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 59.9 | ¥23.51 |
0%
|
| 3-Year Average | 25.4 | ¥9.96 |
-58%
|
| 5-Year Average | 24.4 | ¥9.56 |
-59%
|
| Industry Average | 38.3 | ¥15.01 |
-36%
|
| Country Average | 28.9 | ¥11.34 |
-52%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
¥21.2B
|
/ |
Oct 2025
¥281m
|
= |
|
|
¥21.2B
|
/ |
Dec 2025
¥534.3m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
D
|
Dalian BIO-CHEM Co Ltd
SSE:603360
|
16.6B CNY | 59.9 | 76.9 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 33.9 | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | -84.7 | 41.8 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
523.3T IDR | -58.6 | 28.4 | |
| US |
|
Dow Inc
NYSE:DOW
|
27.7B USD | 171.9 | -10.5 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
169.8B CNY | 18.4 | 19 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
22.5B USD | 37.8 | -29.9 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
675.7B TWD | 201 | 149.5 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
30.6T KRW | 38.2 | -16.8 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
118.8B CNY | 28.7 | 161.3 | |
| IN |
|
Solar Industries India Ltd
NSE:SOLARINDS
|
1.4T INR | 64.5 | 93.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.6 |
| Median | 28.9 |
| 70th Percentile | 52.9 |
| Max | 49 021 |
Other Multiples
Dalian BIO-CHEM Co Ltd
Glance View
Dalian BIO-CHEM Co Ltd, rooted in the bustling port city of Dalian, China, specializes in the innovative production and distribution of fine chemicals and intermediates. Founded with the intent to bridge advanced chemical solutions with practical applications, the company has carved a niche in the global market for its high-quality, sustainable chemical products that serve various industries, including pharmaceuticals, agriculture, and materials science. At the heart of Dalian BIO-CHEM's operations lies its cutting-edge research and development team, consistently pushing the boundaries to create environmentally friendly solutions. These efforts have not only bolstered its reputation but also expanded its reach across continents, as it meets the ever-evolving demands of a global clientele. To drive its revenue, Dalian BIO-CHEM capitalizes on a strategic business model that blends large-scale production efficiencies with bespoke chemical solutions. By maintaining robust relationships with raw material suppliers, the company ensures a stable production pipeline, allowing it to offer competitive pricing without compromising on quality. Its earnings are primarily generated through contracts with multinational corporations and smaller businesses that rely on steady supplies of specialty chemicals. Further diversification into custom synthesis services has enabled Dalian BIO-CHEM to address unique client needs, enhancing customer loyalty and expanding its market presence. This strategic agility positions the company not merely as a supplier, but as a trusted partner in the innovation ecosystem of chemical manufacturing.